DOI: 10.36347/sjmcr.2023.v11i09.025

Pages: 1679-1681

The contemporary management of brain metastases has become progressively more complex as the number of available treatment options increases. The increase in survival seen with improved systemic treatments, and the low morbidity associated with neurosurgical intervention, warrant aggressive and thoughtful management of CNS metastases. Multidisciplinary and collaborative treatment of patients with cancer leads to multifaceted approaches but also the expectation that the treatment of brain metastases should not excessively delay or interfere with the treatment of systemic disease.